CS
SRNE

Candriam SCA’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Candriam SCA’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-310,000
Closed -$1.36M – 859
2018
Q3 		$1.36M Hold
310,000
– – 0.02% 569
2018
Q2 		$2.23M Hold
310,000
– – 0.04% 463
2018
Q1 		$1.6M Buy
+310,000
New +$1.6M 0.03% 522